New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event
February 28, 2024
Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower
February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center…
Read More
American Heart Association’s first scientific statement on artificial intelligence (AI) underscores value of technology’s new clinical insights on CVD patient outcomes
February 28, 2024
Urgent Need to Develop Best Practices to Advance Use of AI in Cardiovascular Care
February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many…
Read More
Health technology giant Royal Philips has announced its proposal to appoint Charlotte Hanneman as member of the Board of Management to fulfill the role of Chief Financial Officer (CFO), filling the position held by Abhijit Bhattacharya, who will be retiring at the end of September after in that role since 2015.
February 28, 2024
Philips Appoints Charlotte Hanneman to succeed Abhijit Bhattacharya as Chief Financial Officer (CFO)
February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of…
Read More
Gen 2 System has potential to reduce cardiac workload and enhance blood flow
February 27, 2024
Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the…
Read More
Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation 
February 27, 2024
Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device 
February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
The Ohio State University Wexner Medical Center is the first in central Ohio to take part in a global clinical trial to use a novel therapy to reduce the size of the left ventricle without open-heart surgery
February 26, 2024
Ohio State First in Central Ohio to Use Novel Heart Failure Therapy
February 26, 2024 — More than 6 million Americans live with heart failure, and about half have an enlarged left…
Read More
The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery
February 26, 2024
Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery
February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center…
Read More
Visualization of the blood vessels in the brain of a patient without early venous filling, meaning without excessive reperfusion of the brain area after removal of the blood clot in the blocked artery.
February 26, 2024
Arterial Connections Improve Treatment Outcomes Following Stroke
February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain…
Read More
FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease
February 23, 2024
Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve
February 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease,…
Read More
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002
February 23, 2024
In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first…
Read More
Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding another research study to Advocate Christ Medical Center, in Oak Lawn, Illinois, just outside Chicago.
February 22, 2024
Research Study on Novel Rehab Program for Heart Failure Patients, Led by Wake Forest University School of Medicine, Expands to Advocate Health Site in Chicago
February 22, 2024 — Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding…
Read More
Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B. Griepp, MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, was named as the new President of the Heart Valve Society
February 22, 2024
Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society
February 22, 2024 — Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the…
Read More
Knowing your family history and getting screened early can be lifesaving
February 22, 2024
Black Families at Increased Risk of Inherited Heart Condition That Can Cause Heart Failure at a Young Age
February 22, 2024 — About 1 in 250 Americans have dilated cardiomyopathy (DCM), a type of inherited heart muscle…
Read More
Athletic Heart will use the Swoop Portable MR Imaging system to provide brain imaging
February 21, 2024
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with…
Read More
Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices
February 21, 2024
Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care
February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology …
Read More
First of its kind artificial heart valve now approved by FDA for treatment of tricuspid regurgitation.
February 21, 2024
Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device
February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart…
Read More
Next-generation skin patch-based monitoring platform enables complete freedom of movement for patients in both healthcare and home settings
February 20, 2024
X-trodes Receives FDA 510(k) Clearance for Wearable "Skin" Solution that Brings Medical-Grade Electrophysiological Monitoring to the Home
February 20, 2024 — X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment…
Read More
The Medtronic APOLLO Clinical Trial is evaluating the safety and efficacy of an investigative device called the Intrepid Transcatheter Mitral Valve Replacement System (TMVR) for moderate-to-severe or severe symptomatic mitral regurgitation (MR) in patients who may be unsuitable for approved transcatheter repair or surgery.
February 20, 2024
Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease
February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an…
Read More
Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery disease (CAD), allowing for reclassification to a lower disease category in 54% of patients
February 20, 2024
Photon-Counting CT Improves Coronary Artery Disease Assessment
February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery…
Read More
The study, titled "Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy" (TaRGET), will be led by the research team at PHRI and will involve collaboration with multiple organizations in addition to AMO Pharma including the Hearts in Rhythm Organization (HiRO). 
February 16, 2024
AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial to Assess Efficacy of Tideglusib in Treatment of Arrhythmogenic Cardiomyopathy
February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now